Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation
The pharmacokinetics and ventilatory effects of oxycodone were studied in six volunteer patients with end‐stage liver cirrhosis before and after orthotopic liver transplantation. Plasma samples and urine were collected for 24 hours after intravenous administration of 0.05 mg/kg oxycodone hydrochlori...
Gespeichert in:
| Veröffentlicht in: | Clinical pharmacology and therapeutics 1997-06, Vol.61 (6), p.655-661 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 661 |
|---|---|
| container_issue | 6 |
| container_start_page | 655 |
| container_title | Clinical pharmacology and therapeutics |
| container_volume | 61 |
| creator | Tallgren, Minna Olkkola, Klaus T. Seppälä, Timo Höckerstedt, Krister Lindgren, Leena |
| description | The pharmacokinetics and ventilatory effects of oxycodone were studied in six volunteer patients with end‐stage liver cirrhosis before and after orthotopic liver transplantation. Plasma samples and urine were collected for 24 hours after intravenous administration of 0.05 mg/kg oxycodone hydrochloride. Concentrations of oxycodone and its metabolites, noroxycodone and oxymorphone, were measured in plasma and urine. The median elimination half‐life of oxycodone was 13.9 hours (range, 4.6 to 24.4 hours) in patients with cirrhosis before transplantation and 3.4 hours (range, 2.6 to 5.1 hours) after transplantation (p < 0.05). Correspondingly, oxycodone clearance increased from 0.26 L/min (range, 0.15 to 0.73 L/min) before transplantation to 1.13 L/min (range, 0.71 to 3.98 L/min) after transplantation (p < 0.05). Oxycodone depress edventilation more strongly before transplantation than after transplantation (p < 0.05). Care should be exercised when oxycodone is used in patients with end‐stage liver disease.
Clinical Pharmacology & Therapeutics (1997) 61, 655–661; doi: |
| doi_str_mv | 10.1016/S0009-9236(97)90100-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79099808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79099808</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5060-8dd36a3b366459e7098cb7e554bbd295670cb4ed0781e16034f0358dbb7473403</originalsourceid><addsrcrecordid>eNqNkE2P0zAQhi0EWsrCT1gpB4TgkN1J_H0DVXxJlbYS5YZk2c5EGNK42O4u_fekbdQzF1vWPPPO-CHkpoHbBhpx9w0AdK1bKt5q-U5DA1CzJ2TRcNrWglP-lCwuyHPyIudf05Nppa7IlW5Bt0wtyI_1T5u21sffYcQSfK7s2FUPOJYw2BLTocK-R19yFfsq_j342MURK4d9THhibV8wVUN4mM6S7Jh3gx2LLSGOL8mz3g4ZX833Nfn-6eNm-aVe3X_-uvywqj0HAbXqOiosdVQIxjVK0Mo7iZwz57pWcyHBO4YdSNVgI4CyHihXnXOSScqAXpM359xdin_2mIvZhuxxmBbBuM9GatBagZpAfgZ9ijkn7M0uha1NB9OAOVo1J6vmqMxoaU5WDZv6buYBe7fF7tI1a5zqr-e6zd4O_aTBh3zBWkmlVMeY92fsMQx4-L_ZZrneLFfrTaO1lMevVueI0ZZ9wkuGH3ZlRv4Bza6eDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79099808</pqid></control><display><type>article</type><title>Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Tallgren, Minna ; Olkkola, Klaus T. ; Seppälä, Timo ; Höckerstedt, Krister ; Lindgren, Leena</creator><creatorcontrib>Tallgren, Minna ; Olkkola, Klaus T. ; Seppälä, Timo ; Höckerstedt, Krister ; Lindgren, Leena</creatorcontrib><description>The pharmacokinetics and ventilatory effects of oxycodone were studied in six volunteer patients with end‐stage liver cirrhosis before and after orthotopic liver transplantation. Plasma samples and urine were collected for 24 hours after intravenous administration of 0.05 mg/kg oxycodone hydrochloride. Concentrations of oxycodone and its metabolites, noroxycodone and oxymorphone, were measured in plasma and urine. The median elimination half‐life of oxycodone was 13.9 hours (range, 4.6 to 24.4 hours) in patients with cirrhosis before transplantation and 3.4 hours (range, 2.6 to 5.1 hours) after transplantation (p < 0.05). Correspondingly, oxycodone clearance increased from 0.26 L/min (range, 0.15 to 0.73 L/min) before transplantation to 1.13 L/min (range, 0.71 to 3.98 L/min) after transplantation (p < 0.05). Oxycodone depress edventilation more strongly before transplantation than after transplantation (p < 0.05). Care should be exercised when oxycodone is used in patients with end‐stage liver disease.
Clinical Pharmacology & Therapeutics (1997) 61, 655–661; doi:</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1016/S0009-9236(97)90100-4</identifier><identifier>PMID: 9209248</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Analgesics ; Analgesics, Opioid - pharmacokinetics ; Analgesics, Opioid - pharmacology ; Biological and medical sciences ; Half-Life ; Humans ; Kidney Function Tests ; Liver Function Tests ; Liver Transplantation ; Medical sciences ; Neuropharmacology ; Oxycodone - pharmacokinetics ; Oxycodone - pharmacology ; Pharmacology. Drug treatments ; Respiratory System - drug effects</subject><ispartof>Clinical pharmacology and therapeutics, 1997-06, Vol.61 (6), p.655-661</ispartof><rights>1997 American Society for Clinical Pharmacology and Therapeutics</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5060-8dd36a3b366459e7098cb7e554bbd295670cb4ed0781e16034f0358dbb7473403</citedby><cites>FETCH-LOGICAL-c5060-8dd36a3b366459e7098cb7e554bbd295670cb4ed0781e16034f0358dbb7473403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2FS0009-9236%2897%2990100-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2FS0009-9236%2897%2990100-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2737784$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9209248$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tallgren, Minna</creatorcontrib><creatorcontrib>Olkkola, Klaus T.</creatorcontrib><creatorcontrib>Seppälä, Timo</creatorcontrib><creatorcontrib>Höckerstedt, Krister</creatorcontrib><creatorcontrib>Lindgren, Leena</creatorcontrib><title>Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>The pharmacokinetics and ventilatory effects of oxycodone were studied in six volunteer patients with end‐stage liver cirrhosis before and after orthotopic liver transplantation. Plasma samples and urine were collected for 24 hours after intravenous administration of 0.05 mg/kg oxycodone hydrochloride. Concentrations of oxycodone and its metabolites, noroxycodone and oxymorphone, were measured in plasma and urine. The median elimination half‐life of oxycodone was 13.9 hours (range, 4.6 to 24.4 hours) in patients with cirrhosis before transplantation and 3.4 hours (range, 2.6 to 5.1 hours) after transplantation (p < 0.05). Correspondingly, oxycodone clearance increased from 0.26 L/min (range, 0.15 to 0.73 L/min) before transplantation to 1.13 L/min (range, 0.71 to 3.98 L/min) after transplantation (p < 0.05). Oxycodone depress edventilation more strongly before transplantation than after transplantation (p < 0.05). Care should be exercised when oxycodone is used in patients with end‐stage liver disease.
Clinical Pharmacology & Therapeutics (1997) 61, 655–661; doi:</description><subject>Analgesics</subject><subject>Analgesics, Opioid - pharmacokinetics</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Kidney Function Tests</subject><subject>Liver Function Tests</subject><subject>Liver Transplantation</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Oxycodone - pharmacokinetics</subject><subject>Oxycodone - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Respiratory System - drug effects</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE2P0zAQhi0EWsrCT1gpB4TgkN1J_H0DVXxJlbYS5YZk2c5EGNK42O4u_fekbdQzF1vWPPPO-CHkpoHbBhpx9w0AdK1bKt5q-U5DA1CzJ2TRcNrWglP-lCwuyHPyIudf05Nppa7IlW5Bt0wtyI_1T5u21sffYcQSfK7s2FUPOJYw2BLTocK-R19yFfsq_j342MURK4d9THhibV8wVUN4mM6S7Jh3gx2LLSGOL8mz3g4ZX833Nfn-6eNm-aVe3X_-uvywqj0HAbXqOiosdVQIxjVK0Mo7iZwz57pWcyHBO4YdSNVgI4CyHihXnXOSScqAXpM359xdin_2mIvZhuxxmBbBuM9GatBagZpAfgZ9ijkn7M0uha1NB9OAOVo1J6vmqMxoaU5WDZv6buYBe7fF7tI1a5zqr-e6zd4O_aTBh3zBWkmlVMeY92fsMQx4-L_ZZrneLFfrTaO1lMevVueI0ZZ9wkuGH3ZlRv4Bza6eDQ</recordid><startdate>199706</startdate><enddate>199706</enddate><creator>Tallgren, Minna</creator><creator>Olkkola, Klaus T.</creator><creator>Seppälä, Timo</creator><creator>Höckerstedt, Krister</creator><creator>Lindgren, Leena</creator><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199706</creationdate><title>Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation</title><author>Tallgren, Minna ; Olkkola, Klaus T. ; Seppälä, Timo ; Höckerstedt, Krister ; Lindgren, Leena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5060-8dd36a3b366459e7098cb7e554bbd295670cb4ed0781e16034f0358dbb7473403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Analgesics</topic><topic>Analgesics, Opioid - pharmacokinetics</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Kidney Function Tests</topic><topic>Liver Function Tests</topic><topic>Liver Transplantation</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Oxycodone - pharmacokinetics</topic><topic>Oxycodone - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Respiratory System - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tallgren, Minna</creatorcontrib><creatorcontrib>Olkkola, Klaus T.</creatorcontrib><creatorcontrib>Seppälä, Timo</creatorcontrib><creatorcontrib>Höckerstedt, Krister</creatorcontrib><creatorcontrib>Lindgren, Leena</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tallgren, Minna</au><au>Olkkola, Klaus T.</au><au>Seppälä, Timo</au><au>Höckerstedt, Krister</au><au>Lindgren, Leena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>1997-06</date><risdate>1997</risdate><volume>61</volume><issue>6</issue><spage>655</spage><epage>661</epage><pages>655-661</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>The pharmacokinetics and ventilatory effects of oxycodone were studied in six volunteer patients with end‐stage liver cirrhosis before and after orthotopic liver transplantation. Plasma samples and urine were collected for 24 hours after intravenous administration of 0.05 mg/kg oxycodone hydrochloride. Concentrations of oxycodone and its metabolites, noroxycodone and oxymorphone, were measured in plasma and urine. The median elimination half‐life of oxycodone was 13.9 hours (range, 4.6 to 24.4 hours) in patients with cirrhosis before transplantation and 3.4 hours (range, 2.6 to 5.1 hours) after transplantation (p < 0.05). Correspondingly, oxycodone clearance increased from 0.26 L/min (range, 0.15 to 0.73 L/min) before transplantation to 1.13 L/min (range, 0.71 to 3.98 L/min) after transplantation (p < 0.05). Oxycodone depress edventilation more strongly before transplantation than after transplantation (p < 0.05). Care should be exercised when oxycodone is used in patients with end‐stage liver disease.
Clinical Pharmacology & Therapeutics (1997) 61, 655–661; doi:</abstract><cop>New York, NY</cop><pub>Nature Publishing</pub><pmid>9209248</pmid><doi>10.1016/S0009-9236(97)90100-4</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9236 |
| ispartof | Clinical pharmacology and therapeutics, 1997-06, Vol.61 (6), p.655-661 |
| issn | 0009-9236 1532-6535 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79099808 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Analgesics Analgesics, Opioid - pharmacokinetics Analgesics, Opioid - pharmacology Biological and medical sciences Half-Life Humans Kidney Function Tests Liver Function Tests Liver Transplantation Medical sciences Neuropharmacology Oxycodone - pharmacokinetics Oxycodone - pharmacology Pharmacology. Drug treatments Respiratory System - drug effects |
| title | Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20and%20ventilatory%20effects%20of%20oxycodone%20before%20and%20after%20liver%20transplantation&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Tallgren,%20Minna&rft.date=1997-06&rft.volume=61&rft.issue=6&rft.spage=655&rft.epage=661&rft.pages=655-661&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1016/S0009-9236(97)90100-4&rft_dat=%3Cproquest_cross%3E79099808%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79099808&rft_id=info:pmid/9209248&rfr_iscdi=true |